Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cara Therapeutics Inc. | -5.520% | -10.565% | -12.393% | -82.568% | -4.182% | -93.892% | -95.907% |
Caredx Inc | 3.310% | 49.016% | 63.475% | 89.060% | 21.422% | -74.156% | - |
Carisma Therapeutics Inc. | -1.610% | -9.733% | -25.193% | -88.482% | -50.584% | -96.481% | -97.657% |
CASI Pharmaceuticals Inc. | -1.850% | - | - | - | - | - | - |
Catalyst Biosciences Inc | -0.200% | - | - | - | - | - | - |
Catalyst Pharmaceutical Partners Inc | 1.400% | 8.274% | 6.571% | 23.043% | -1.898% | 235.645% | 422.805% |
Champions Oncology Inc | -2.710% | -4.018% | -4.867% | 11.399% | -10.788% | -42.282% | - |
Checkpoint Therapeutics | - | - | - | - | - | - | - |
Chembio Diagnostics Inc. | - | - | - | - | - | - | - |
Chemocentryx Inc. | 0.570% | - | - | - | - | - | - |
Chiasma Inc | -0.710% | - | - | - | - | - | - |
Chimerix Inc. | 5.020% | 3.747% | 7.309% | -6.557% | 15.440% | -85.634% | -70.185% |
Chinook Therapeutics Inc. | -1.090% | - | - | - | - | - | - |
Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -44.561% | - |
Clovis Oncology Inc. | - | - | - | - | - | - | - |
Cocrystal Pharma Inc. | 8.920% | 16.327% | 20.423% | -29.918% | 10.323% | -84.677% | - |
Codexis Inc. | 2.330% | 2.800% | 25.019% | 38.047% | 19.618% | -77.629% | -79.327% |
Coherus Bioscien. | -1.300% | -8.142% | -8.710% | -57.519% | -36.908% | -83.322% | -87.672% |
Collegium Pharmaceutical Inc | 2.040% | -11.243% | -9.639% | 44.231% | 9.489% | 64.835% | - |
Concert Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Corbus Pharmaceuticals Holding Inc. | -2.010% | 9.392% | 3.125% | 30693.157% | 30693.157% | -3.720% | - |
Corcept Therapeutics Inc. | 0.820% | 12.341% | 15.747% | 17.339% | -14.733% | 46.171% | - |
CorMedix Inc | 0.840% | -9.907% | -16.174% | 0.000% | 40.936% | 2.553% | -20.763% |
Corvus Pharmaceuticals Inc | 1.170% | 7.605% | 35.043% | 5.922% | 24.737% | -5.200% | -49.332% |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |